• News/Events
    • News
    • Press Releases
    • Events
  • About Us
    • Team
    • Advisors
    • Board
  • Investors
  • Contact
freyaa-logo
  • Pelvic Monitoring
  • Healthcare Professionals
    • UroGyn
    • OB/GYNs
    • Physical Therapists
  • Resources
    • Publications
    • News/Events
      • News
      • Press Releases
      • Events
    • About Us
      • Team
      • Advisors
      • Board
    • Investors
    • Contact
Growing ‘femtech’ Sector Part of BioMedSA’s Annual Startup Pitch Fest

Growing ‘femtech’ Sector Part of BioMedSA’s Annual Startup Pitch Fest

by ricky@robotcreative.com | Mar 5, 2025 | News

A San Antonio area startup has developed a device to help women suffering from pelvic floor disorders. Read more in the San Antonio Business Journal article.
Freyya Featured on South Texas Business Lawyers

Freyya Featured on South Texas Business Lawyers

by ricky@robotcreative.com | Feb 23, 2025 | For HCP'S, Pitch Events

Freyya CEO Gabriele Niederauer, PhD interviewed by Matthew Duke about what we are doing at Freyya through developing a wearable biofeedback device to train and monitor the pelvic floor conditions. Watch the interview...
Celebrating the Next Wave of Innovation at Altitude Lab, Introducing Our Latest Cohort

Celebrating the Next Wave of Innovation at Altitude Lab, Introducing Our Latest Cohort

by ricky@robotcreative.com | Jul 5, 2024 | News

Freyya was awarded residency at Altitude Labs, a healthcare incubator building a community of diverse entrepreneurs in Utah.
Growing ‘femtech’ Sector Part of BioMedSA’s Annual Startup Pitch Fest

Women’s Health Device Takes Center Stage at BexarBio Pitch Event

by ricky@robotcreative.com | Nov 1, 2023 | News

Freyya received a $275,000 SBIR Phase 1 grant from NSF to design the measuring sensors, evaluate the ergonomic design and develop the related hardware and software.
Freyya Awarded SBIR PHASE 1 Grant

Freyya Awarded SBIR PHASE 1 Grant

by ricky@robotcreative.com | Jan 15, 2021 | News

Media Inquiries

Email us
info@freyya.com

The Freyya™ pelvic biofeedback product is covered by a patent pending application filed under the Patent Cooperation Treaty (PCT). The Freyya™ pelvic biofeedback product is not cleared or approved by the U.S. Food and Drug Administration (FDA) or CE Marked for any specific use; and, therefore is not available for commercial distribution in the United States or Europe.

Pelvic Monitoring

Healthcare Professionals

UroGyn
OB/GYNs
Physical Therapists

Resources

Publications

News / Events

News
Press Releases
Events

About Us

Team
Advisors
Board

Investors

Contact

freyaa-logo
  • Follow
  • Follow

Copyright © 2025 Freyya™,  All Rights Reserved.